The use of psychoactive substances to enhance sexual experience (hereinafter referred to as “chemsex”) has become a significant issue in medical and psychotherapeutic care in recent years. It is primarily men who have sex with men (MSM) who practice chemsex, with a focus on specific substances such as methamphetamine (crystal meth), mephedrone, GHB/GBL and ketamine.
Autoren
- Tanja Schliebe
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies
Advances in breast cancer therapy in the age of molecular diagnostics
- Current overview of evidence, mechanisms and clinical implications
Apolipoprotein E and neuropsychiatric symptoms in neurocognitive disorders
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Parkinson's disease
Individual therapy management for an optimized outcome – an update
- Latent autoimmune diabetes in adults (LADA)
Looks like type 2, but is type 1
- Treatment of vitiligo